Abstract
Minimally invasive endoscopic procedures are often employed for the surgical removal of kidney stones. Traditionally, large stones are removed by (standard) percutaneous nephrolithotomy (SPCNL). Although effective for the clearance of large stone burdens, SPCNL is associated with significant morbidity. Therefore, in an effort to reduce this morbidity, while preserving efficacy, mini-PCNL (MPCNL) with a smaller tract size (<20 French) was developed. Several studies suggest that MPCNL has a comparable stone-free rate to SPCNL. However, the question of lower morbidity with MPCNL remains unanswered. In this review, we describe the equipment, indications, and efficacy of MPCNL with particular attention to its value over traditional minimally invasive stone removal techniques.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Scales Jr CD, Smith AC, Hanley JM, Saigal CS. Urologic diseases in America P. prevalence of kidney stones in the United States. Eur Urol. 2012;62:160–5.
Ordon M, Urbach D, Mamdani M, Saskin R, RJ DAH, Pace KT. The surgical management of kidney stone disease: a population based time series analysis. J Urol. 2014;192:1450–6.
Preminger GM, Assimos DG, Lingeman JE, et al. Chapter 1: AUA guideline on management of staghorn calculi: diagnosis and treatment recommendations. J Urol. 2005;173:1991–2000.
Turk C, Petrik A, Sarica K. EAU Guidelines on interventional treatment for urolithiasis. Eur Urol. 2015.
de la Rosette J, Assimos D, Desai M, et al. The Clinical Research Office of the Endourological Society Percutaneous Nephrolithotomy Global Study: indications, complications, and outcomes in 5803 patients. J Endourol. 2011;25:11–7.
Yamaguchi A, Skolarikos A, Buchholz NP, et al. Operating times and bleeding complications in percutaneous nephrolithotomy: a comparison of tract dilation methods in 5,537 patients in the Clinical Research Office of the Endourological Society Percutaneous Nephrolithotomy Global Study. J Endourol. 2011;25:933–9.
Jackman SV, Docimo SG, Cadeddu JA, Bishoff JT, Kavoussi LR, Jarrett TW. The “mini-perc” technique: a less invasive alternative to percutaneous nephrolithotomy. World J Urol. 1998;16:371–4.
Wright AE, Somani BK, Rukin NJ. Proposition for new terminologies in PCNL: what does ‘ultra-mini-micro’ actually mean? Urolithiasis. 2014;42:539–40. This article comprehensively describes the hardware available for the currently available minimally-invasive percutaneous nephrolithotomy systems.
Ganpule AP, Bhattu AS, Desai M. PCNL in the twenty-first century: role of Microperc, Miniperc, and Ultraminiperc. World J Urol. 2015;33(2):235–40.
Zeng G, Wan S, Zhao Z, et al. Super-mini percutaneous nephrolithotomy (SMP): a new concept in technique and instrumentation. BJU Int. 2015. doi:10.1111/bju.13242.
Cheng F, Yu W, Zhang X, Yang S, Xia Y, Ruan Y. Minimally invasive tract in percutaneous nephrolithotomy for renal stones. J Endourol. 2010;24:1579–82.
Mishra S, Sharma R, Garg C, Kurien A, Sabnis R, Desai M. Prospective comparative study of miniperc and standard PNL for treatment of 1 to 2 cm size renal stone. BJU Int. 2011;108(6):896–9. discussion899–900.
Knoll T, Wezel F, Michel MS, Honeck P, Wendt-Nordahl G. Do patients benefit from miniaturized tubeless percutaneous nephrolithotomy? A comparative prospective study. J Endourol. 2010;24(7):1075–9. This article is a contemporary meta-analysis comparing standard percutaneous nephrolithotomy to mini-percutaneous nephrolithotomy in terms of stone free rate, operative characteristics, complications, and patient reported outcomes. It should be considered the highest-level of available evidence demonstrating that standard percutaneous nephrolithotomy and mini-percutaneous nephrolithotomy have equivalent stone free rate.
Zhu W, Liu Y, Liu L, Lei M, Yuan J, Wan SP. Minimally invasive versus standard percutaneous nephrolithotomy: a meta-analysis. Urolithiasis. 2015;43(6):563–70.
Matlaga BR, Hodges SJ, Shah OD, Passmore L, Hart LJ, Assimos DG. Percutaneous nephrostolithotomy: predictors of length of stay. J Urol. 2004;172:1351–4.
Kirac M, Bozkurt OF, Tunc L, Guneri C, Unsal A, Biri H. Comparison of retrograde intrarenal surgery and mini-percutaneous nephrolithotomy in management of lower-pole renal stones with a diameter of smaller than 15 mm. Urolithiasis. 2013;41(3):241–6.
Sabnis RB, Jagtap J, Mishra S, Desai M. Treating renal calculi 1–2 cm in diameter with minipercutaneous or retrograde intrarenal surgery: a prospective comparative study. BJU Int. 2012;110((8 Pt B)):E346–9.
Lee JW, Park J, Lee SB, Son H, Cho SY, Jeong H. Mini-percutaneous nephrolithotomy vs retrograde intrarenal surgery for renal stones larger than 10 mm: a prospective randomized controlled trial. Urology. 2015;86:873–7.
Kruck S, Anastasiadis AG, Herrmann TR, et al. Minimally invasive percutaneous nephrolithotomy: an alternative to retrograde intrarenal surgery and shockwave lithotripsy. World J Urol. 2013;31(6):1555–61.
Kiremit MC, Guven S, Sarica K, et al. Contemporary management of medium-sized (10–20 mm) renal stones: a retrospective multicenter observational study. J Endourol. 2015;29(7):838–43.
Kumar A, Kumar N, Vasudeva P, Kumar Jha S, Kumar R, Singh H. A prospective, randomized comparison of shock wave lithotripsy, retrograde intrarenal surgery and miniperc for treatment of 1 to 2 cm radiolucent lower calyceal renal calculi: a single center experience. J Urol. 2015;193(1):160–4.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Sasha C. Druskin and Justin B. Ziemba each declare no potential conflicts of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
This article is part of the Topical Collection on Minimally Invasive Surgery
Rights and permissions
About this article
Cite this article
Druskin, S.C., Ziemba, J.B. Minimally Invasive (“Mini”) Percutaneous Nephrolithotomy: Classification, Indications, and Outcomes. Curr Urol Rep 17, 30 (2016). https://doi.org/10.1007/s11934-016-0591-5
Published:
DOI: https://doi.org/10.1007/s11934-016-0591-5